[an error occurred while processing this directive]

高等学校化学研究 ›› 2015, Vol. 31 ›› Issue (1): 78-83.doi: 10.1007/s40242-015-4282-4

• Articles • 上一篇    下一篇

Synthesis and Antitumor Activity of Capecitabine Derivatives

JIA Xuedong1,2, LIU Xiujun1, WANG Jian3, WANG Minghua1, GUO Huiyuan1, LIU Mingliang1   

  1. 1. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P. R. China;
    2. The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China;
    3. No.5 Hospital of Harbin, Harbin 150040, P. R. China
  • 收稿日期:2014-07-25 修回日期:2014-09-11 出版日期:2015-02-01 发布日期:2014-10-20
  • 通讯作者: LIU Mingliang, E-mail:lmllyx@126.com;LIU Xiujun, E-mail:liuxiujun2000@163.com E-mail:lmllyx@126.com;liuxiujun2000@163.com
  • 基金资助:

    Supported by the National S&T Major Special Project on Major New Drug Innovations of China(Nos.2012ZX09301002-001-017/023, 2014ZX09507009-003) and the National Natural Science Foundation of China(No.81373267-003).

Synthesis and Antitumor Activity of Capecitabine Derivatives

JIA Xuedong1,2, LIU Xiujun1, WANG Jian3, WANG Minghua1, GUO Huiyuan1, LIU Mingliang1   

  1. 1. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, P. R. China;
    2. The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China;
    3. No.5 Hospital of Harbin, Harbin 150040, P. R. China
  • Received:2014-07-25 Revised:2014-09-11 Online:2015-02-01 Published:2014-10-20
  • Contact: LIU Mingliang, E-mail:lmllyx@126.com;LIU Xiujun, E-mail:liuxiujun2000@163.com E-mail:lmllyx@126.com;liuxiujun2000@163.com
  • Supported by:

    Supported by the National S&T Major Special Project on Major New Drug Innovations of China(Nos.2012ZX09301002-001-017/023, 2014ZX09507009-003) and the National Natural Science Foundation of China(No.81373267-003).

摘要:

A series of capecitabine derivatives with a Boc group at the N4-position was synthesized and their in vitro antitumor activities against HepG2(liver hepatocellular carcinoma) were primarily evaluated. Some compounds were chosen for further evaluation of their in vivo efficacy on nude mice xenografted human hepatoma HepG2. The results showed that compounds 3 and 6 had considerable in vivo activity against HepG2, with tumor growth inhibition rates of 70% and 64% on day 21, respectively, and 56% and 55% on day 35, respectively, which are roughly comparable to capecitabine(74% and 59% on days 21 and 35, respectively).

关键词: Capecitabine, Derivative, Antitumor activity

Abstract:

A series of capecitabine derivatives with a Boc group at the N4-position was synthesized and their in vitro antitumor activities against HepG2(liver hepatocellular carcinoma) were primarily evaluated. Some compounds were chosen for further evaluation of their in vivo efficacy on nude mice xenografted human hepatoma HepG2. The results showed that compounds 3 and 6 had considerable in vivo activity against HepG2, with tumor growth inhibition rates of 70% and 64% on day 21, respectively, and 56% and 55% on day 35, respectively, which are roughly comparable to capecitabine(74% and 59% on days 21 and 35, respectively).

Key words: Capecitabine, Derivative, Antitumor activity